Recruiting A Study of SRSD216 in Patients With Elevated Lipoprotein (a) NCT07172646 Conditions Dyslipidemias, Hyperlipidemias, Hyperlipoproteinemia (a), +4 more Locations Site 01 — Beijing, Beijing Municipality, China View Trial Details
Active, Not Recruiting An Open Label Extension (OLE) Study to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230) NCT05900141 Conditions Cardiovascular Diseases, Dyslipidemias, Hyperlipidemias, +5 more Locations Novartis Investigative Site — Frankfurt am Main, Hesse, Germany Novartis Investigative Site — Berlin, Germany Novartis Investigative Site — Cloppenburg, Germany Novartis Investigative Site — Dresden, Germany View more locations Show fewer locations Loading locations... View Trial Details
